Clinical outcomes of primary bladder carcinoma in situ in a contemporary series - Wikidata - wikimedia - TriplyDB

Clinical outcomes of primary bladder carcinoma in situ in a contemporary series

Clinical outcomes of primary bladder carcinoma in situ in a contemporary series

http://www.wikidata.org/entity/Q34480396

about

Diagnosis of narrow-band imaging in non-muscle-invasive bladder cancer: a systematic review and meta-analysis Best practice in the treatment of nonmuscle invasive bladder cancer.Association of smoking status with prognosis in bladder cancer: A meta-analysis.Long-term outcomes of intravesical therapy for non-muscle invasive bladder cancer.Current strategies in the treatment of non-muscle-invasive bladder cancer.Follow-up procedures for non-muscle-invasive bladder cancer: an update.Urethral carcinoma in situ: recognition and management.The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer - A New Analysis.Single Arm Phase I/II Study of Everolimus and Intravesical Gemcitabine in Patients with Primary or Secondary Carcinoma In Situ of the Bladder who failed Bacillus Calmette Guerin (NCT01259063).Prognostic Effect of Carcinoma In Situ in Muscle-invasive Urothelial Carcinoma Patients Receiving Neoadjuvant Chemotherapy.Conservative management and female gender are associated with increased cancer-specific death in patients with isolated primary urothelial carcinoma in situ.[Urine cytology - update 2013. A systematic review of recent literature].Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumors at diagnosis.Seventeen-year follow-up of the prospective randomized Nordic CIS study: BCG monotherapy versus alternating therapy with mitomycin C and BCG in patients with carcinoma in situ of the urinary bladder.

P2860

Q26859123-428174B7-8443-491E-B42D-16DC9F33ECAE Q35688392-62085C23-BC3A-47F2-BADA-3EF4675E9396 Q36207920-551C9FB2-FC69-4870-9EC0-236EA1DBDE76 Q37813081-9693C731-7424-470B-8BA2-D3B7C7CE1ADA Q38048823-FEF50907-F210-4FFB-9B12-3A6D381D09D7 Q38055500-434EF1F7-5276-4423-8ED6-FF68702279E3 Q39013320-91D1C670-71C2-4ADC-97A5-445D7E70321D Q39634006-1BE7C9E5-3890-453E-9126-5B24C60E68FC Q40197490-9A27CE7B-D5D4-4964-A0F9-296A6F8BA98F Q42237719-224CAA62-1C74-4725-A770-169052DCD993 Q44508630-7CCFF42F-9DD9-4BBC-B0A3-10CC3E752744 Q45139625-A5D59C06-2E47-4CFF-8A89-6843AA80D813 Q47262331-A07A5AFC-8916-41E2-BCB0-7E342AB1E1F1 Q51820157-A585B8DF-E2F4-4042-8CB8-33C998B228EE

P2860

Clinical outcomes of primary bladder carcinoma in situ in a contemporary series

http://www.wikidata.org/entity/Q34480396

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Clinical outcomes of primary bladder carcinoma in situ in a contemporary series

@ast

Clinical outcomes of primary bladder carcinoma in situ in a contemporary series

@en

Clinical outcomes of primary bladder carcinoma in situ in a contemporary series

@nl

type

label

Clinical outcomes of primary bladder carcinoma in situ in a contemporary series

@ast

Clinical outcomes of primary bladder carcinoma in situ in a contemporary series

@en

Clinical outcomes of primary bladder carcinoma in situ in a contemporary series

@nl

prefLabel

Clinical outcomes of primary bladder carcinoma in situ in a contemporary series

@ast

Clinical outcomes of primary bladder carcinoma in situ in a contemporary series

@en

Clinical outcomes of primary bladder carcinoma in situ in a contemporary series

@nl

P1433

Q34480396-FE7BF4A4-E607-412C-83F0-8B79DEAB502C

P1476

Q34480396-40B8D3CA-2107-4580-828F-3925AE3620AE

P2093

Q34480396-05864B44-FDB7-4178-B59A-F083ADFE0C64

Q34480396-2F5C107A-4DEB-49E4-8700-9C958BBEF2A1

Q34480396-6DC6197F-080A-4F0B-A0B9-BAAEAA693638

Q34480396-949223FA-3725-4D40-9AD9-4D4ECEC3030F

Q34480396-99A4C229-2332-41CF-889B-D063DD81306F

Q34480396-B6107E8E-2E66-4B1D-82F3-47C28EBB2082

P2860

Q34480396-127C8EED-051E-4108-8E19-6F810561AAD9

Q34480396-28D94BB6-D3CA-4131-8BEA-86AF9D00F3B7

Q34480396-56A8B211-A426-4729-9234-2B4FCEA8AE36

Q34480396-65527840-CA0B-4ADC-A948-D639B54357C9

Q34480396-80DD98F4-BAB3-4525-B517-46FAAC9BC4ED

Q34480396-989DF4CE-3314-486D-B16E-91568A6AE4F8

Q34480396-9A5B5B10-DBDA-4D31-B069-D50D164AEFDE

Q34480396-D4020E38-EA4B-4354-AD10-18557F78940A

Q34480396-E2FCF892-6B16-4293-9B84-6DB294D0DA8F

Q34480396-E74D000E-B194-4269-A470-3DE1E029F4E3

P304

Q34480396-FACDBCC5-A2A3-4FA2-8BCC-F14215EF868F

P31

Q34480396-7FAACE33-777F-4979-A5BD-0D23EE1E6118

P356

Q34480396-504BAF18-C51A-4BD8-AFB9-012837EFE49D

P407

Q34480396-A54FD128-29B5-420C-A3B6-55C6680EA9C7

P433

Q34480396-B56EFCA1-884F-49C1-9738-C5FC120C13CD

P478

Q34480396-24201FB6-5701-4481-B81D-E57787AD28BF

P50

Q34480396-A97A84FC-CA2E-44A2-B111-24CBDA154FE1

Q34480396-ADA2EBA2-F658-475C-9B0C-3D2F9A766008

Q34480396-CFE59F07-2B21-4849-93A7-CFBB6CE75E6A

P577

Q34480396-CC74AA22-E1FD-4D92-A25F-AF2E1FDF2E38

P698

Q34480396-7FB831E7-7103-49CC-B666-DC59374BC80F

P932

Q34480396-F8151033-D4AA-4241-A145-2EC02CE181B9

P356

J.JURO.2010.03.032

P1433

The Journal of Urology

P1476

Clinical outcomes of primary bladder carcinoma in situ in a contemporary series

@en

P2093

Angel M Cronin

http://www.w3.org/2001/XMLSchema#string

Caroline J Savage

http://www.w3.org/2001/XMLSchema#string

Daher C Chade

http://www.w3.org/2001/XMLSchema#string

Guilherme Godoy

http://www.w3.org/2001/XMLSchema#string

Harry W Herr

http://www.w3.org/2001/XMLSchema#string

Shahrokh F Shariat

http://www.w3.org/2001/XMLSchema#string

P2860

Carcinoma in situ.

High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder.

Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update.

Carcinoma in situ of the urinary bladder: review of clinicopathologic characteristics with an emphasis on aspects related to molecular diagnostic techniques and prognosis.

Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy.

Carcinoma in situ of the urinary tract.

Clinical observations on sixty-nine cases of in situ carcinoma of the urinary bladder.

Updated concepts and treatment of carcinoma in situ.

Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach?

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

P304

74-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JURO.2010.03.032

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

184

http://www.w3.org/2001/XMLSchema#string

P50

Bernard H Bochner

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20546806

http://www.w3.org/2001/XMLSchema#string

P932

4226045

http://www.w3.org/2001/XMLSchema#string